Evan Y. Yu
University of Washington(US)Fred Hutch Cancer Center(US)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments, Cancer Immunotherapy and Biomarkers, Urinary and Genital Oncology Studies, Radiopharmaceutical Chemistry and Applications
Most-Cited Works
- → Integrative Clinical Genomics of Advanced Prostate Cancer(2015)3,599 cited
- → Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy(2012)2,765 cited
- → Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial(2016)2,185 cited
- → Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study(2010)1,081 cited
- → Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer(2016)752 cited
- → Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial(2021)635 cited